Navigation Links
Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber
Date:8/27/2008

ANTONY, France, August 27 /PRNewswire-FirstCall/ --

- Oralair(R) Grasses 300IR Highly Positive Clinical Results in a Pharmacodynamic Study Conducted in an Allergen Challenge Chamber

Stallergenes S.A. announces the highly positive results of a new study conducted in an Allergen Challenge Chamber (ACC).

The study on Oralair(R) Grasses included 86 adult patients exposed to grass pollen challenge with different treatment durations: 1 week, 1 month, 2 and 4 months without a titration phase. Use of rescue medication was not allowed.
The outcomes of this trial in line with the objectives were:

- An onset of action starting on the seventh day

(statistically significant at one month)

- An efficacy plateau reached on challenge at the first month

- A highly statistically significant effect of Oralair(R)

Grasses versus placebo (p=0.0003) on the average symptom score (RTSS).

The magnitude of efficacy (34%)1 was similar to the findings of the

Previous studies VO34 (in adults) and VO52 (in a paediatric population)

- A Cohen score of 0.79 corresponding to a large effect size

Safety results, with only well-known local adverse events, and efficacy results were consistent with the findings of Oralair(R) Grasses studies previously conducted in adults (VO34) and children (VO52) in phase III trials.

"This study has demonstrated a clear consistency with the outcomes of previous pivotal studies. It opens the way for ACC as a new tool for phase II studies reducing the unpredictability of pollination. Moreover, it confirms the therapeutic effect of Oralair(R) Grasses and the very fast onset of action on the symptoms," said Olivier de Beaumont.

1 on median scores

ABOUT THE STUDY

This was a randomised, double-blind, parallel-group, placebo-controlled, single centre, phase I study to assess, subsequent to allergen challenge in an allergen exposition chamber, the efficacy
'/>"/>

SOURCE Stallergenes
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing
2. Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events
3. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
4. BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; A Vaccine Candidate for Genital Herpes
5. febit and TGen Collaborate to Study New DNA Capture Method
6. Study Shows Benefits of a High Omega-3 Diet in Older Adults
7. NewCardio Announces Positive Results From Third Clinical Validation Study
8. M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases
9. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
10. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
11. Icon Bioscience Completes Enrollment in Phase I Study of Novel Ophthalmic Drug Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... N.Y. , Feb. 26, 2015 ... year at the Clearwater Beach Hilton to provide ... technology to plant reliability professionals from around the ... a stellar collection of leaders in the field ... the demand for excellence continues with this year,s ...
(Date:2/26/2015)... 2015 ABIVAX, a clinical stage biotech ... announced that it has dosed in New Zealand ... trial of ABX203 which is taking place in several countries ... is designed to assess whether ABX203 can deliver a significant ... controlling viral load for a much longer period of time ...
(Date:2/26/2015)... , February 26, 2015 Medtronic, Inc. ... (U.S) are the leaders in the Saudi Arabia ... neuromodulation market and is expected to lead the market during ... Inc. is the top player in the market, and owns ... specific applications. Interstim and Entera Neurostimulator are some of the ...
Breaking Medicine Technology:UE Systems Renowned "Ultrasound World" Conference Celebrates its 11th Year 2ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 2ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 3ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 4ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 5Middle East & Africa Internal Neurostimulation/Neuromodulation Market is Expected to Reach $6.1 Million by 2019, at a CAGR of 17.9% from 2014 to 2019 2Middle East & Africa Internal Neurostimulation/Neuromodulation Market is Expected to Reach $6.1 Million by 2019, at a CAGR of 17.9% from 2014 to 2019 3Middle East & Africa Internal Neurostimulation/Neuromodulation Market is Expected to Reach $6.1 Million by 2019, at a CAGR of 17.9% from 2014 to 2019 4
... CENTER CITY, Minn., Dec. 21 William Fals-Stewart,Ph.D., professor ... Rochester in,Rochester, New York, has earned the 2007 Dan ... of partner involvement in the,treatment of female alcoholics. Sponsored ... honors a single published article by a researcher,who has ...
... Health care license revenue increases more than 100% ... 20 HealthMedia, the global,leader in scalable behavior ... continued to experience rapid growth,throughout the third quarter ... HealthMedia Connect(TM) product and was honored for its,leadership ...
Cached Medicine Technology:Fals-Stewart Earns Hazelden's 2007 Dan Anderson Research Award 2Fals-Stewart Earns Hazelden's 2007 Dan Anderson Research Award 3Fals-Stewart Earns Hazelden's 2007 Dan Anderson Research Award 4HealthMedia's Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships 2HealthMedia's Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships 3
(Date:2/26/2015)... Wound Care Advantage (WCA), an ... executive team by adding three key members possessing many ... time two WCA team members were promoted to key ... founded in 2002 and is one of the few ... team believes that providing outstanding patient care is the ...
(Date:2/26/2015)... February 26, 2015 SpendWell Health, ... its launch to its first customer today, opening ... their covered dependents. , SpendWell delivers the ... services, combining real-time price transparency with e-commerce. SpendWell’s ... of routine health care services and allows shoppers ...
(Date:2/26/2015)... Catalent Pharma Solutions, the ... and development solutions for drugs, biologics and ... expanded capabilities within its European Clinical Supply ... in response to increased customer demand for ... highly-potent or temperature-sensitive investigational medical products continues ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 Participants ... Initiatives: What’s Working? What’s Not? What’s New? ,” ... dual-eligibles programs to achieve strong outcomes for duals-plan ... been happening in the implementation phase of programs ... been made? Which ones need to be implemented ...
(Date:2/26/2015)... February 26, 2015 The Reproductive Science ... their newly renovated office in Lawrenceville, NJ. ... Center of New Jersey’s physicians, and NJ Top Docs, ... care in the areas of infertility and reproductive medicine. ... excellent success rates and providing current, high quality medical ...
Breaking Medicine News(10 mins):Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 2Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 3Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 4Health News:SpendWell Launches New Online Health Care Marketplace to Large Employer Group 2Health News:SpendWell Launches New Online Health Care Marketplace to Large Employer Group 3Health News:Catalent Expands European Clinical Packaging Capabilities, Highlighting Growing Industry Need for Specialty Handling 2Health News:Catalent Expands European Clinical Packaging Capabilities, Highlighting Growing Industry Need for Specialty Handling 3Health News:Upcoming AIS Virtual Conference Will Explain What Is and Is Not Working in Medicare-Medicaid Dual Eligibles Programs 2Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 2Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 3
... 12 (HealthDay News) -- A toxic component of a plant ... failure and upper urinary tract cancer, researchers warn. Aristolochic ... used for centuries and still are used in many countries. ... cancer in Taiwan concluded that aristolochic acid is a primary ...
... THURSDAY, April 12 (HealthDay News) -- More unmarried women who ... a new government report shows. Twenty-seven percent of births ... threefold increase from 1985, researchers from the U.S. Centers for ... births outside of marriage, one parent isn,t present. But our ...
... of its kind study conducted by researchers at Boston ... one fall requiring first responder emergency medical services response ... Logan International Airport, with 37 percent of those incidents ... done at the request of the Massachusetts Port Authority ...
... a study published in the Journal of ... risk factors for heart disease, type 2 diabetes ... who did not consume nuts. Tree nut (almonds, ... pistachios and walnuts) consumption specifically, was associated with ...
... international study found that bone marrow transplants are not ... lymphoblastic leukemia (ALL) who fail to attain clinical remission ... induction therapy. The largest study ever of such ... who achieved 10-year survival rates of 72 percent after ...
... Reporter , WEDNESDAY, April 11 (HealthDay News) -- Some ... people with Parkinson,s disease without aggravating other disease symptoms ... Nearly 1 million people in the United States are ... by tremor, slowness and/or rigidity. Parkinson,s disease and depression ...
Cached Medicine News:Health News:Herbal Remedy Ingredient Tied to Cancer, Kidney Failure 2Health News:More Unmarried Couples Having Babies: CDC 2Health News:BMC study shows diverting passengers to elevators could help reduce falls at Logan Airport 2Health News:Tree nut consumption associated with lower body weight and lower prevalence of health risks 2Health News:Chemotherapy proves life-saving for some leukemia patients who fail induction therapy 2Health News:Chemotherapy proves life-saving for some leukemia patients who fail induction therapy 3Health News:Newer Antidepressants May Be Safe for Parkinson's Patients 2Health News:Newer Antidepressants May Be Safe for Parkinson's Patients 3
... Kendall provides hospitals and alternate care ... tracheostomy care trays which offer the ... control. Designed with the guidance of ... trays provide exactly what is required ...
... Per-fit™ flexible PVC tube with a tapered ... designed to reduce insertion force and more ... kit s unique obturator/dilator design is engineered ... an easier transition through the tissue into ...
... Self-contained kits provide convenience and cost control. ... care trays offer a variety of wound ... management of the tracheostomized patient. , ... and trays with disposable inner cannula for ...
... Self-contained kits provide convenience and cost control. ... care trays offer a variety of wound ... management of the tracheostomized patient. , ... and trays with disposable inner cannula for ...
Medicine Products: